Jun 23, 2026 08:26AM

Jun 23, 2026 08:25AM

Jun 22, 2026 08:45AM

May 13, 2026 04:05PM

May 6, 2026 08:20AM

Mar 30, 2026 08:23AM

Mar 30, 2026 08:20AM SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026

Mar 25, 2026 04:05PM

Mar 18, 2026 04:05PM

Mar 9, 2026 08:35AM

Mar 5, 2026 08:20AM

Feb 9, 2026 08:20AM

Feb 9, 2026 08:20AM

Jan 29, 2026 08:25AM SeaStar Medical to Present at Upcoming Noble Capital Markets Emerging Growth Virtual Equity Conference

Jan 7, 2026 08:13AM

Jan 7, 2026 08:13AM

Jan 6, 2026 08:53AM

Dec 23, 2025 04:25PM

Dec 23, 2025 04:25PM

Dec 2, 2025 08:27AM

Dec 2, 2025 08:27AM SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI

Nov 20, 2025 09:52AM

Nov 17, 2025 08:45AM

Nov 17, 2025 08:43AM

Nov 13, 2025 04:05PM

Nov 5, 2025 10:03AM

Sep 29, 2025 08:36AM

Sep 29, 2025 08:36AM SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children

Sep 24, 2025 04:28PM

Sep 24, 2025 04:22PM

Sep 23, 2025 08:24AM

Sep 23, 2025 08:23AM

Sep 4, 2025 06:13PM

Sep 2, 2025 08:22AM

Aug 13, 2025 04:05PM SeaStar Medical Reports Second Quarter 2025 Financial Results and Provides Business Updates

Aug 7, 2025 10:00AM

Aug 6, 2025 08:33AM

Aug 6, 2025 08:33AM

Jul 31, 2025 03:02PM

Jul 31, 2025 03:01PM

Jul 22, 2025 08:20AM

Jul 22, 2025 08:20AM SeaStar Medical Reports Positive Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) from the First 20 SAVE Surveillance Registry Patients

Jul 16, 2025 08:45AM

Jul 16, 2025 08:45AM

Jul 10, 2025 03:30PM

Jul 10, 2025 03:29PM

Jul 8, 2025 08:05AM

Jul 2, 2025 04:25PM

Jul 2, 2025 04:25PM SeaStar Medical Announces Positive Nasdaq Listing Determination

Jun 27, 2025 10:01AM

324,409 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All